(Q35183649)

7 August 2017

title

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers (English)

1 reference

7 August 2017

Alicia J Allred

1

1 reference

7 August 2017

Carolyn J Bowen

2

1 reference

7 August 2017

Jung Wook Park

3

1 reference

7 August 2017

Bin Peng

4

1 reference

7 August 2017

Daphne D Williams

5

1 reference

7 August 2017

Mary Beth Wire

6

1 reference

7 August 2017

Edmund Lee

7

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

British Journal of Clinical Pharmacology

7 August 2017

published in

1 reference

7 August 2017

volume

72

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

321-329

1 reference

Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

The effect of gemfibrozil on the pharmacokinetics of rosuvastatin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3162661

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

28 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03972.X

10.1111/J.1365-2125.2011.03972.X

21 January 2018

Identifiers

DOI

1 reference

release_yihkieij5jhptjpw7h6gtjjpme

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yihkieij5jhptjpw7h6gtjjpme

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3162661

1 reference

7 August 2017

1 reference